Golimumab Subcutaneous and Lanthanum Chewable Tablets
Determining the interaction of Golimumab Subcutaneous and Lanthanum Chewable Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: lanthanum carbonate
Brand name: Fosrenol
Synonyms: Lanthanum carbonate, Lanthanum
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Lanthanum Powder
- Golimumab Subcutaneous-Lantus
- Golimumab Subcutaneous-Lantus SoloStar
- Golimumab Subcutaneous-Lantus SoloStar (Insulin Glargine (U-100) Cartridge Systems and Pens)
- Golimumab Subcutaneous-Lantus Solostar (Insulin Glargine (U-300) Pens)
- Golimumab Subcutaneous-Lantus Solostar Pen
- Lanthanum Chewable Tablets-GoLYTELY
- Lanthanum Chewable Tablets-Gonadorelin
- Lanthanum Chewable Tablets-Gonadorelin Intravenous, Injection
- Lanthanum Chewable Tablets-Gonadotropin, Chorionic
- Lanthanum Chewable Tablets-Gonal-F
- Lanthanum Chewable Tablets-Gonal-f RFF